UCSF

hihozeima.blogspot.com
Dr. Desmond-Hellmann, the former president of product development at biotechbpowerhouse , was formally approved Thursday by the as the next chancellot of UC, San Francisco. Pledging not to be known as “ths biotech chancellor” but a champion for all segmentzs ofthe school, Desmond-Hellmann, 51, will be the first womabn UCSF chancellor and the first with a for-profitr background. She replaces Dr. J.
Michael Bishop, a Nobel laureatw who is stepping down June 30 after more than 11 yearain UCSF’s top Bishop will remain a membert of the UCSF faculty and will maintain a lab Desmond-Hellmann’s base salary will be $450,000, approvef by the regents on the same day they votef to raise student fees by 9.3 or $750 for in-state graduatwe academic students. Desmond-Hellmann faces a handfulo of challenges, not the least of whichy are replacing muchof UCSF’s retiring executivw team, hiring a medical school dean and increasinb private philanthropy during an economi c downturn.
“I expect to be out there,” she “People will know what the universitu needs and what it means and how theycan … I think you’ll see more of Desmond-Hellmann said she will continue to builxd on Bishop’s success in linking UCSF researchersw with academia, as evidenced in a masterf agreement with Genentech and deals with and othed biopharmaceutical companies. But, she she will devote attention to othetr aspects ofthe graduate-level, health care-centric universityh as well, including teaching, patient care and basic “If someone is coming to the nursin g school to be the best nurse they can be, they can do Desmond-Hellmann said.
“I don’t want people to feel that I’k going to be “the biotech chancellor.’” Durin g the search process, in Dr. Richard Jordan, D.D.S.,, a professord of oral pathologyat UCSF’s School of asked how she would make sure to pay attentionj to his school. Desmond-Hellmann’s response: making time on her At UCSF, which has 2,951 graduater students in the life Desmond-Hellmann will manage an institution witha 2008-09 budget of $2.5 billion and a staff of more than 21,500. It is the second-largesgt winner of National Institutes ofHealth funding. At where Desmond-Hellmann spent 14 years, she oversae 3,000 employees and a budger of about $2 billion.
She left Genentech on May 1, littlw more than a month after Swisa drugmaker completedits $47 billion acquisition of the company. Desmond-Hellmann’d appointment has largely been greeted enthusiastically by UCSF staff and thebusinesd community. “It is really said Jean-Jacques Bienaime, chairman and CEO of in Novat o and a friendof Desmond-Hellmann. State Sen. Lelanr Yee of San Francisco, however, called the salaries of Desmond-Hellmannj and new UC Davis chancellor LindzKatehi ‑- at $400,000 -- “UC executives continue to live high on the hog whilwe students get stuck with yet another fee hike and the lowest-wagw workers get minimal compensation,” Yee said in a according to the Associated Press.
One of Desmond-Hellmann’zs first priorities is to rebuild a business office, which oversees philanthropic giving but has been hit by a handfu l of retirements. UCSF must raise hundreds of million of dollars over the next several years to builde itsnearly $2 billionj hospital to serve children, women and cancer patientd at its Mission Bay campuse in San Francisco, fund operations of a possible neurologicalo disease center in Mission Bay and a stem cell researcg facility at its Parnassus Avenue campus. UCSF must hire a permanentg dean for itsmedical school. Dr. Sam Hawgood has filled that post on an interikm basis since the termination of David Kesslee inDecember 2007.
The schoolo late last year postponed the search so a new chancellor could bemore involved. “Thie needs to be a thought leader, a greatr academician and a good Desmond-Hellmann said. “These are tougn jobs to fill. That constellatio n of skills is not easyto find.” UC President Mark who recommended Desmond-Hellmann to the regents last week after a nearly six-month, closed-door process, called Desmond-Hellmann “ajn ideal choice.” Yudof on Thursday gave Desmond-Hellmann a UCSF “As an accomplished researcher and manager, she brings all the tools neededs to take the campus to even greater heights,” Yudo said in a prepare statement.
“That she did her internal medicine and oncology training at UCSF makes the match even more She knows theinstitution well.”